<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rsp</journal-id><journal-title-group><journal-title xml:lang="ru">Научно-практическая ревматология</journal-title><trans-title-group xml:lang="en"><trans-title>Rheumatology Science and Practice</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1995-4484</issn><issn pub-type="epub">1995-4492</issn><publisher><publisher-name>IMA-PRESS, LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14412/1995-4484-2012-1187</article-id><article-id custom-type="elpub" pub-id-type="custom">rsp-1101</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>СТРЕССОВЫЕ ФАКТОРЫ И ПСИХИЧЕСКИЕ РАССТРОЙСТВА ПРИ БОЛЕЗНИ ШЕГРЕНА: СОВРЕМЕННЫЕ НАПРАВЛЕНИЯ ИССЛЕДОВАНИЙ</article-title><trans-title-group xml:lang="en"><trans-title>STRESS FACTORS AND MENTAL DISORDERS IN SJOGREN'S DISEASE: MODERN TRENDS IN RESEARCH</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Shelomkova</surname><given-names>Olga Aleksandrovna</given-names></name><name name-style="western" xml:lang="en"><surname>Shelomkova</surname><given-names>Olga Aleksandrovna</given-names></name></name-alternatives><email xlink:type="simple">shelomkova-olga@ram-bler.ru</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Veltishchev</surname><given-names>D Yu</given-names></name><name name-style="western" xml:lang="en"><surname>Veltishchev</surname><given-names>D Yu</given-names></name></name-alternatives><email xlink:type="simple">-</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Васильев</surname><given-names>В. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Vasilyev</surname><given-names>V I</given-names></name></name-alternatives><email xlink:type="simple">-</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лисицына</surname><given-names>Т. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Lisitsyna</surname><given-names>T A</given-names></name></name-alternatives><email xlink:type="simple">-</email></contrib></contrib-group><pub-date pub-type="collection"><year>2012</year></pub-date><pub-date pub-type="epub"><day>15</day><month>10</month><year>2012</year></pub-date><volume>50</volume><issue>5</issue><issue-title>№5 (2012)</issue-title><fpage>85</fpage><lpage>89</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Shelomkova O.A., Veltishchev D.Y., Васильев В.И., Лисицына Т.А., 2012</copyright-statement><copyright-year>2012</copyright-year><copyright-holder xml:lang="ru">Shelomkova O.A., Veltishchev D.Y., Васильев В.И., Лисицына Т.А.</copyright-holder><copyright-holder xml:lang="en">Shelomkova O.A., Veltishchev D.Y., Vasilyev V.I., Lisitsyna T.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://rsp.mediar-press.net/rsp/article/view/1101">https://rsp.mediar-press.net/rsp/article/view/1101</self-uri></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">&lt;div&gt;&lt;p&gt;Аронов П.В., Старовойтова М.Н., Ковалевская О.Б. и др. Стресс и депрессия у больных системной склеродермией (обзор зарубежной литературы). Псих. расстр. общ. мед. 2009; 4: 17-9.&lt;/p&gt;&lt;p&gt;Васильев В.И. Болезнь Шегрена. Рус. мед. журн. 1998; 18: 1206—10.&lt;/p&gt;&lt;p&gt;Васильев В.И. Клиника, диагностика и дифференциальная диагностика болезни Шегрена. Рус. мед. журн. Ревматология 2008; 16(10): 638—49.&lt;/p&gt;&lt;p&gt;Вельтищев Д.Ю., Марченко А.С., Серавина О.Ф. и др. Аффективно-стрессовая модель депрессии: практическое внедрение в ревматологической практике. Cons Med. Психиатр. психофарм. 2009; 5: 17-21.&lt;/p&gt;&lt;p&gt;Дрождина Е.Н. Психотравмирующие факторы и личностная аффективность при стрессовых расстройствах у подростков с ювенильным хроническим артритом. Современные принципы терапии и реабилитации психических больных: Матер. рос. конф. М., 2006; 154—5.&lt;/p&gt;&lt;p&gt;Евменова Н.Н., Гурвич В.Б. Взаимодействие стоматологического и психического статусов при синдроме и болезни Шегрена. Вопр. соц. клин. психиатр. наркол. 1989; 4(1): 143—5.&lt;/p&gt;&lt;p&gt;Зелтынь А.Е., Вельтищев Д.Ю., Фофанова Ю.С. и др. Ревматоидный артрит и депрессия: патогенетическая роль стрессовых факторов (обзор литературы). Псих. расстр. общ. мед. 2010; 1: 48-51.&lt;/p&gt;&lt;p&gt;Зелтынь А.Е., Фофанова Ю.С., Лисицына Т.А. и др. Хронический стресс и депрессия у больных ревматоидным артритом. Соц. клин. психиатр. 2009; 2: 69-76.&lt;/p&gt;&lt;p&gt;Лисицына Т.А., Вельтищев Д.Ю., Серавина О.Ф. и др. Варианты психических нарушений у больных системной красной волчанкой. Науч.-практич. ревматол. 2008; 4: 21-7.&lt;/p&gt;&lt;p&gt;Лисицына Т.А., Вельтищев Д.Ю., Серавина О.Ф. и др. Распространенность психических нарушений у больных системной красной волчанкой: связь с активностью заболевания и сопутствующими хроническими расстройствами. Тер. арх. 2009; 6: 10—6.&lt;/p&gt;&lt;p&gt;Александер Ф. Психосоматическая медицина. Принципы и применение. М.: Ин-т общегуманитарных исследований, 2009; 224—33.&lt;/p&gt;&lt;p&gt;Pelizza L., Bonacini F., Ferrari A. Psychiatric disorder as clinical presentation of primary Sjö gren's syndrome: two case reports. Ann Gen Psychiatr 2010; 1: 9-12.&lt;/p&gt;&lt;p&gt;Van Dam A.P., Wekking E.M., Callewaert J.A. et al. Psychiatric symptoms before systemic lupus erythematosus is diagnosed. Rheumatol Int 1994; 14(2): 57—62.&lt;/p&gt;&lt;p&gt;De Vries E., Schipperijn A.J., Breedveld F.C. Antinuclear antibodies in psychiatric patients. Acta Psychiatr Scand 1994; 89(4): 289—90.&lt;/p&gt;&lt;p&gt;Academic highlights of the primary care companion. Translating evidence of depression and physical symptoms into effective clinical practice. J Clin Psychiatr 2007; 9(4): 295—302.&lt;/p&gt;&lt;p&gt;Strain J.J., Blumenfield M. Challenges for Consultation-Lialison Psychiatry in the 21st Century. Psychosomatics 2008; 49(2): 93—6.&lt;/p&gt;&lt;p&gt;Valtysdottir S.T. Primary Sjö gren's syndrome. Clinical studies with reference to hormonal status, psychiatric symptoms and well-being. Comprehensive summaries of Uppsala dissertations from the faculty of medicine 984. Acta Univers Upsaliensis. Uppsala, 2001.&lt;/p&gt;&lt;p&gt;Moutsopoulos H., Youinou P. New developments in Sjö gren's syndrome. Curr Opin Rheumatol 1991; 3: 815-22.&lt;/p&gt;&lt;p&gt;Drosos A.A., Angelopoulos N. Personality and psychopathology in patients with primary Sjö gren's syndrome. Ter Arkh 1988; 60(4): 49—52.&lt;/p&gt;&lt;p&gt;Harbuz M. Neuroendocrine function and chronic inflammatory stress. Exp Physiol 2002; 87: 519-25.&lt;/p&gt;&lt;p&gt;Malinow K.L., Molina R., Gordon B. et al. Neuropsychiatric dysfunction in primary Sjö gren's syndrome. Ann Intern Med 1985; 103(3): 344—50.&lt;/p&gt;&lt;p&gt;Vitali C., Tavoni A., Neri R. Fibromyalgia features in patients with primary Sjö gren's syndrome: evidence of a relationship with psychological depression. Scand J Rheumatol 1989; 18(1): 21—7.&lt;/p&gt;&lt;p&gt;Mukai M., Sagawa A., Baba Y. Neuro-psychiatric symptom associated with primary Sjö gren's syndrome. Ryumachi 1990; 30(2): 109—18.&lt;/p&gt;&lt;p&gt;Hietaharju A., Yli-Kerttula U., Häkkinen V., Frey H. Nervous system manifestations in Sjö gren's syndrome. Acta Neurol Scand 1990; 81(2): 144—52.&lt;/p&gt;&lt;p&gt;Cox P., Hales R. CNS Sjö gren's syndrome: an underrecognized and underappreciated neuropsychiatric disorder. J Neuropsych Clin Neurosci 1999; 11: 241-7.&lt;/p&gt;&lt;p&gt;Valtysdottir S.T., Gudbjornsson B., Lindqvist U. et al. Anxiety and depression in patients with primary Sjö gren's syndrome. J Rheumatol 2000; 27: 165-9.&lt;/p&gt;&lt;p&gt;Harboe E., Tjensvoll A.B., Maroni S. et al. Neuropsychiatric syndromes in patients with systemic lupus erythematousus and primary Sjö gren's syndrome — a comparative population-based study. Ann Rheum Dis 2009; 68(10): 1541-6.&lt;/p&gt;&lt;p&gt;Segal B., Bowman S.J., Fox P.C. et al. Primary Sjö gren's syndrome: health experiences and predictors of health quality among patients in the United States. Health Qual Life Outcomes 2009; 7: 46.&lt;/p&gt;&lt;p&gt;Valtysdottir S.T., Gudbjörnsson B., Hällgren R., Hetta J. Psychological well-being in patients with primary Sjö gren's syndrome. Clin Exp Rheumatol 2000; 18(5): 597—600.&lt;/p&gt;&lt;p&gt;Robson S.C., Klemp P., Meyers O.L. Central nervous system manifestations of Sjö gren's syndrome. A case report. S Afr Med J 1986; 69(3): 196-7.&lt;/p&gt;&lt;p&gt;Tishler M., Barak Y., Paran D. et al. Sleep disturbances, fibromyalgia and primary Sjö gren's syndrome. Clin Exp Rheumatol 1997; 15(1): 71-4.&lt;/p&gt;&lt;p&gt;Jiunn-Horng Kang, Herng-Ching Lin. Comorbidities in patients with primary Sjö gren's syndrome: a registry-based case-control study. J Rheumatol 2010; 37(6): 1188—94.&lt;/p&gt;&lt;p&gt;Karaiskos D., Mavragani C.P., Makaroni S. Stress, coping strategies and social support in patients with primary Sjö gren's syndrome prior to disease onset: a retrospective case-control study. Ann Rheum Dis 2009; 68(1): 40—6.&lt;/p&gt;&lt;p&gt;Drosos A.A., Andonopoulos A.P., Lagos G. et al. Neuropsychiatric abnormalities in primary Sjö gren's syndrome. Clin Exp Rheumatol 1989; 7(2): 207-9.&lt;/p&gt;&lt;p&gt;Hyphantis T., Mantis D., Voulgari P.V. et al. The psychological defensive profile of primary Sjö gren's syndrome patients and its relationship to health-related quality of life. Clin Exp Rheumatol 2011; 29(3): 485—93.&lt;/p&gt;&lt;p&gt;De Brouwer S.J.M., Kraaimaat F.W., Sweep F.C.G.J. et al. Experimental stress in inflammatory rheumatic diseases: a review of psychophysiological stress responses. Arthr Res Ther 2010; 12(3): R89.&lt;/p&gt;&lt;p&gt;Cutolo M., Straub R.H. Stress as a risk factor in the pathogenesis of rheumatoid arthritis. Neuroimmunomodulation 2006; 13: 277-82.&lt;/p&gt;&lt;p&gt;Straub R.H., Dhabhar F.S., Bijlsma J.W., Cutolo M. How psychological stress via hormones and nerve fibers may exacerbate rheumatoid arthritis. Arthr Rheum 2005; 52: 16-26.&lt;/p&gt;&lt;p&gt;Walker J.G., Littlejohn G.O., McMurray N.E., Cutolo M. Stress system response and rheumatoid arthritis: a multilevel approach. Rheumatology (Oxford) 1999; 38: 1050-7.&lt;/p&gt;&lt;p&gt;Zautra A.J., Hamilton N.A., Potter P., Smith B. Field research on the relationship between stress and disease activity in rheumatoid arthritis. Ann NY Acad Sci 1999; 876: 397-412.&lt;/p&gt;&lt;p&gt;Ampelas J., Wattiaux M., van Amerongen A. Psychiatric manifestations of systemic lupus erythematosus and Sjö gren's syndrome. Encephale 2001; 27: 588-99.&lt;/p&gt;&lt;p&gt;Inal V., Kitapcioglu G., Karabulut G. et al. Evaluation of quality of life in relation to anxiety and depression in primary Sjö gren's syndrome. Mod Rheumatol 2010; 20(6): 588—97.&lt;/p&gt;&lt;p&gt;Utset K., Fink J., Doninger N.A. Prevalence of neurocognitive dysfunction and other clinical manifestations in disabled patients with systemic lupus erythematosus. J Rheumatol 2006; 33: 531-8.&lt;/p&gt;&lt;p&gt;Mauch E., Völk C., Kratzsch G. et al. Neurological and neuropsychiatric dysfunction in primary Sjogren's syndrome. Acta Neurol Scand 1994; 89(1): 31-5.&lt;/p&gt;&lt;p&gt;Alexander E. Neurological disease in Sjogren's syndrome: mononuclear inflammatory vasculopathy affecting central/peripheral nervous system and muscle. Rheum Dis Clin North Am 1993; 19: 869-908.&lt;/p&gt;&lt;p&gt;Gudbjö rnsson B., Broman J.E., Hetta J. et al. Sleep disturbances in patients with primary Sjö gren's syndrome. Br J Rheumatol 1993; 32(12): 1072-6.&lt;/p&gt;&lt;p&gt;Theander L., Strömbeck B., Mandl T. et al. Sleepiness or fatigue? Can we detect treatable causes of tiredness in primary Sjö gren's syndrome? Rheumatology (Oxford) 2010; 49(6): 1177—83.&lt;/p&gt;&lt;p&gt;Barendregt P., Visser M., Smets E. Fatigue in primary Sjö gren's syndrome. Ann Rheum Dis 1998; 57(5): 291-5.&lt;/p&gt;&lt;p&gt;Dickerson S.S., Kemeny M.E. Acute stressors and cortisol responses: a theoretical integration and synthesis of laboratory research. Psychol Bull 2004; 130: 355-91.&lt;/p&gt;&lt;p&gt;Westhoff G., Dörner T., Zink A. Fatigue and depression predict physician visits and work disability in women with primary Sjö gren's syndrome: results from a cohort study. Rheumatology (Oxford) 2012; 51(2): 262-9.&lt;/p&gt;&lt;p&gt;Segal B., Thomas W., Rogers T. et al. Prevalence, severity, and predictors of fatigue in subjects with primary Sjö gren's syndrome. Arthr Rheum 2008; 59(12): 1780-7.&lt;/p&gt;&lt;p&gt;Vriezekolk J.E., Geenen R., Hartkamp A., Godaert G.L. Psychological and somatic predictors of perceived and measured ocular dryness of patients with primary Sjö gren's syndrome. J Rheumatol 2005; 32(12): 2351-5.&lt;/p&gt;&lt;p&gt;Sirois A.D., Natelson B. Clinicopathological findings consistent with primary Sjö gren's syndrome in a subset of patients diagnosed with chronic fatigue syndrome: preliminary observations. J Rheumatol 2001; 28(1): 126-31.&lt;/p&gt;&lt;p&gt;Andersson S.I., Manthorpe R., Theander E. Situational patterns in coping with primary Sjö gren's syndrome. Psychol Health Med 2001; 6(1): 29-40.&lt;/p&gt;&lt;p&gt;Johnson E.O., Kostandi M., Moutsopoulos H.M. Hypothalamic-pituitary-adrenal axis function in Sjö gren's syndrome: mechanisms of neuroendocrine and immune system homeostasis. Ann NY Acad Sci 2006; 1088: 41-51.&lt;/p&gt;&lt;p&gt;Dohrenbusch R., Grü terich M., Genth E. Fibromyalgia and Sjö gren's syndrome-clinical and methodological aspects. J Rheumatol 1996; 55(1): 19-27.&lt;/p&gt;&lt;p&gt;Champey J., Corruble E., Gottenberg J.E. et al. Quality of life and psychological status in patients with primary Sjö gren's syndrome and sicca symptoms without autoimmune features. Arthr Rheum 2006; 55: 451-7.&lt;/p&gt;&lt;p&gt;Karaiskos D., Mavragani C.P., Sinno M.H. et al. Psychopathological and personality features in primary Sjö gren's syndrome - associations with autoantibodies to neuropeptides. Rheumatology (Oxford) 2010; 49(9): 1762-9.&lt;/p&gt;&lt;p&gt;Wang Y., Wang S.L., Zou Y.Z. Psychiatric and central nervous system involvement in Sjö gren's syndrome. Zhonghua Kou Qiang Yi Xue Za Zhi 2004; 39(2): 158—60.&lt;/p&gt;&lt;p&gt;Herbert J., Goodyer I.M, Grossman A.B. et al. Do corticosteroids damage the brain? J Neuroendocrinol 2006; 18(6): 393—411.&lt;/p&gt;&lt;p&gt;Lewis D.A., Smith R.E. Steroid-induced psychiatric syndromes. A report of 14 cases and a review of the literature. J Affect Disord 1983; 5(4): 319-32.&lt;/p&gt;&lt;/div&gt;&lt;br /&gt;</mixed-citation><mixed-citation xml:lang="en">&lt;div&gt;&lt;p&gt;Аронов П.В., Старовойтова М.Н., Ковалевская О.Б. и др. Стресс и депрессия у больных системной склеродермией (обзор зарубежной литературы). Псих. расстр. общ. мед. 2009; 4: 17-9.&lt;/p&gt;&lt;p&gt;Васильев В.И. Болезнь Шегрена. Рус. мед. журн. 1998; 18: 1206—10.&lt;/p&gt;&lt;p&gt;Васильев В.И. Клиника, диагностика и дифференциальная диагностика болезни Шегрена. Рус. мед. журн. Ревматология 2008; 16(10): 638—49.&lt;/p&gt;&lt;p&gt;Вельтищев Д.Ю., Марченко А.С., Серавина О.Ф. и др. Аффективно-стрессовая модель депрессии: практическое внедрение в ревматологической практике. Cons Med. Психиатр. психофарм. 2009; 5: 17-21.&lt;/p&gt;&lt;p&gt;Дрождина Е.Н. Психотравмирующие факторы и личностная аффективность при стрессовых расстройствах у подростков с ювенильным хроническим артритом. Современные принципы терапии и реабилитации психических больных: Матер. рос. конф. М., 2006; 154—5.&lt;/p&gt;&lt;p&gt;Евменова Н.Н., Гурвич В.Б. Взаимодействие стоматологического и психического статусов при синдроме и болезни Шегрена. Вопр. соц. клин. психиатр. наркол. 1989; 4(1): 143—5.&lt;/p&gt;&lt;p&gt;Зелтынь А.Е., Вельтищев Д.Ю., Фофанова Ю.С. и др. Ревматоидный артрит и депрессия: патогенетическая роль стрессовых факторов (обзор литературы). Псих. расстр. общ. мед. 2010; 1: 48-51.&lt;/p&gt;&lt;p&gt;Зелтынь А.Е., Фофанова Ю.С., Лисицына Т.А. и др. Хронический стресс и депрессия у больных ревматоидным артритом. Соц. клин. психиатр. 2009; 2: 69-76.&lt;/p&gt;&lt;p&gt;Лисицына Т.А., Вельтищев Д.Ю., Серавина О.Ф. и др. Варианты психических нарушений у больных системной красной волчанкой. Науч.-практич. ревматол. 2008; 4: 21-7.&lt;/p&gt;&lt;p&gt;Лисицына Т.А., Вельтищев Д.Ю., Серавина О.Ф. и др. Распространенность психических нарушений у больных системной красной волчанкой: связь с активностью заболевания и сопутствующими хроническими расстройствами. Тер. арх. 2009; 6: 10—6.&lt;/p&gt;&lt;p&gt;Александер Ф. Психосоматическая медицина. Принципы и применение. М.: Ин-т общегуманитарных исследований, 2009; 224—33.&lt;/p&gt;&lt;p&gt;Pelizza L., Bonacini F., Ferrari A. Psychiatric disorder as clinical presentation of primary Sjö gren's syndrome: two case reports. Ann Gen Psychiatr 2010; 1: 9-12.&lt;/p&gt;&lt;p&gt;Van Dam A.P., Wekking E.M., Callewaert J.A. et al. Psychiatric symptoms before systemic lupus erythematosus is diagnosed. Rheumatol Int 1994; 14(2): 57—62.&lt;/p&gt;&lt;p&gt;De Vries E., Schipperijn A.J., Breedveld F.C. Antinuclear antibodies in psychiatric patients. Acta Psychiatr Scand 1994; 89(4): 289—90.&lt;/p&gt;&lt;p&gt;Academic highlights of the primary care companion. Translating evidence of depression and physical symptoms into effective clinical practice. J Clin Psychiatr 2007; 9(4): 295—302.&lt;/p&gt;&lt;p&gt;Strain J.J., Blumenfield M. Challenges for Consultation-Lialison Psychiatry in the 21st Century. Psychosomatics 2008; 49(2): 93—6.&lt;/p&gt;&lt;p&gt;Valtysdottir S.T. Primary Sjö gren's syndrome. Clinical studies with reference to hormonal status, psychiatric symptoms and well-being. Comprehensive summaries of Uppsala dissertations from the faculty of medicine 984. Acta Univers Upsaliensis. Uppsala, 2001.&lt;/p&gt;&lt;p&gt;Moutsopoulos H., Youinou P. New developments in Sjö gren's syndrome. Curr Opin Rheumatol 1991; 3: 815-22.&lt;/p&gt;&lt;p&gt;Drosos A.A., Angelopoulos N. Personality and psychopathology in patients with primary Sjö gren's syndrome. Ter Arkh 1988; 60(4): 49—52.&lt;/p&gt;&lt;p&gt;Harbuz M. Neuroendocrine function and chronic inflammatory stress. Exp Physiol 2002; 87: 519-25.&lt;/p&gt;&lt;p&gt;Malinow K.L., Molina R., Gordon B. et al. Neuropsychiatric dysfunction in primary Sjö gren's syndrome. Ann Intern Med 1985; 103(3): 344—50.&lt;/p&gt;&lt;p&gt;Vitali C., Tavoni A., Neri R. Fibromyalgia features in patients with primary Sjö gren's syndrome: evidence of a relationship with psychological depression. Scand J Rheumatol 1989; 18(1): 21—7.&lt;/p&gt;&lt;p&gt;Mukai M., Sagawa A., Baba Y. Neuro-psychiatric symptom associated with primary Sjö gren's syndrome. Ryumachi 1990; 30(2): 109—18.&lt;/p&gt;&lt;p&gt;Hietaharju A., Yli-Kerttula U., Häkkinen V., Frey H. Nervous system manifestations in Sjö gren's syndrome. Acta Neurol Scand 1990; 81(2): 144—52.&lt;/p&gt;&lt;p&gt;Cox P., Hales R. CNS Sjö gren's syndrome: an underrecognized and underappreciated neuropsychiatric disorder. J Neuropsych Clin Neurosci 1999; 11: 241-7.&lt;/p&gt;&lt;p&gt;Valtysdottir S.T., Gudbjornsson B., Lindqvist U. et al. Anxiety and depression in patients with primary Sjö gren's syndrome. J Rheumatol 2000; 27: 165-9.&lt;/p&gt;&lt;p&gt;Harboe E., Tjensvoll A.B., Maroni S. et al. Neuropsychiatric syndromes in patients with systemic lupus erythematousus and primary Sjö gren's syndrome — a comparative population-based study. Ann Rheum Dis 2009; 68(10): 1541-6.&lt;/p&gt;&lt;p&gt;Segal B., Bowman S.J., Fox P.C. et al. Primary Sjö gren's syndrome: health experiences and predictors of health quality among patients in the United States. Health Qual Life Outcomes 2009; 7: 46.&lt;/p&gt;&lt;p&gt;Valtysdottir S.T., Gudbjörnsson B., Hällgren R., Hetta J. Psychological well-being in patients with primary Sjö gren's syndrome. Clin Exp Rheumatol 2000; 18(5): 597—600.&lt;/p&gt;&lt;p&gt;Robson S.C., Klemp P., Meyers O.L. Central nervous system manifestations of Sjö gren's syndrome. A case report. S Afr Med J 1986; 69(3): 196-7.&lt;/p&gt;&lt;p&gt;Tishler M., Barak Y., Paran D. et al. Sleep disturbances, fibromyalgia and primary Sjö gren's syndrome. Clin Exp Rheumatol 1997; 15(1): 71-4.&lt;/p&gt;&lt;p&gt;Jiunn-Horng Kang, Herng-Ching Lin. Comorbidities in patients with primary Sjö gren's syndrome: a registry-based case-control study. J Rheumatol 2010; 37(6): 1188—94.&lt;/p&gt;&lt;p&gt;Karaiskos D., Mavragani C.P., Makaroni S. Stress, coping strategies and social support in patients with primary Sjö gren's syndrome prior to disease onset: a retrospective case-control study. Ann Rheum Dis 2009; 68(1): 40—6.&lt;/p&gt;&lt;p&gt;Drosos A.A., Andonopoulos A.P., Lagos G. et al. Neuropsychiatric abnormalities in primary Sjö gren's syndrome. Clin Exp Rheumatol 1989; 7(2): 207-9.&lt;/p&gt;&lt;p&gt;Hyphantis T., Mantis D., Voulgari P.V. et al. The psychological defensive profile of primary Sjö gren's syndrome patients and its relationship to health-related quality of life. Clin Exp Rheumatol 2011; 29(3): 485—93.&lt;/p&gt;&lt;p&gt;De Brouwer S.J.M., Kraaimaat F.W., Sweep F.C.G.J. et al. Experimental stress in inflammatory rheumatic diseases: a review of psychophysiological stress responses. Arthr Res Ther 2010; 12(3): R89.&lt;/p&gt;&lt;p&gt;Cutolo M., Straub R.H. Stress as a risk factor in the pathogenesis of rheumatoid arthritis. Neuroimmunomodulation 2006; 13: 277-82.&lt;/p&gt;&lt;p&gt;Straub R.H., Dhabhar F.S., Bijlsma J.W., Cutolo M. How psychological stress via hormones and nerve fibers may exacerbate rheumatoid arthritis. Arthr Rheum 2005; 52: 16-26.&lt;/p&gt;&lt;p&gt;Walker J.G., Littlejohn G.O., McMurray N.E., Cutolo M. Stress system response and rheumatoid arthritis: a multilevel approach. Rheumatology (Oxford) 1999; 38: 1050-7.&lt;/p&gt;&lt;p&gt;Zautra A.J., Hamilton N.A., Potter P., Smith B. Field research on the relationship between stress and disease activity in rheumatoid arthritis. Ann NY Acad Sci 1999; 876: 397-412.&lt;/p&gt;&lt;p&gt;Ampelas J., Wattiaux M., van Amerongen A. Psychiatric manifestations of systemic lupus erythematosus and Sjö gren's syndrome. Encephale 2001; 27: 588-99.&lt;/p&gt;&lt;p&gt;Inal V., Kitapcioglu G., Karabulut G. et al. Evaluation of quality of life in relation to anxiety and depression in primary Sjö gren's syndrome. Mod Rheumatol 2010; 20(6): 588—97.&lt;/p&gt;&lt;p&gt;Utset K., Fink J., Doninger N.A. Prevalence of neurocognitive dysfunction and other clinical manifestations in disabled patients with systemic lupus erythematosus. J Rheumatol 2006; 33: 531-8.&lt;/p&gt;&lt;p&gt;Mauch E., Völk C., Kratzsch G. et al. Neurological and neuropsychiatric dysfunction in primary Sjogren's syndrome. Acta Neurol Scand 1994; 89(1): 31-5.&lt;/p&gt;&lt;p&gt;Alexander E. Neurological disease in Sjogren's syndrome: mononuclear inflammatory vasculopathy affecting central/peripheral nervous system and muscle. Rheum Dis Clin North Am 1993; 19: 869-908.&lt;/p&gt;&lt;p&gt;Gudbjö rnsson B., Broman J.E., Hetta J. et al. Sleep disturbances in patients with primary Sjö gren's syndrome. Br J Rheumatol 1993; 32(12): 1072-6.&lt;/p&gt;&lt;p&gt;Theander L., Strömbeck B., Mandl T. et al. Sleepiness or fatigue? Can we detect treatable causes of tiredness in primary Sjö gren's syndrome? Rheumatology (Oxford) 2010; 49(6): 1177—83.&lt;/p&gt;&lt;p&gt;Barendregt P., Visser M., Smets E. Fatigue in primary Sjö gren's syndrome. Ann Rheum Dis 1998; 57(5): 291-5.&lt;/p&gt;&lt;p&gt;Dickerson S.S., Kemeny M.E. Acute stressors and cortisol responses: a theoretical integration and synthesis of laboratory research. Psychol Bull 2004; 130: 355-91.&lt;/p&gt;&lt;p&gt;Westhoff G., Dörner T., Zink A. Fatigue and depression predict physician visits and work disability in women with primary Sjö gren's syndrome: results from a cohort study. Rheumatology (Oxford) 2012; 51(2): 262-9.&lt;/p&gt;&lt;p&gt;Segal B., Thomas W., Rogers T. et al. Prevalence, severity, and predictors of fatigue in subjects with primary Sjö gren's syndrome. Arthr Rheum 2008; 59(12): 1780-7.&lt;/p&gt;&lt;p&gt;Vriezekolk J.E., Geenen R., Hartkamp A., Godaert G.L. Psychological and somatic predictors of perceived and measured ocular dryness of patients with primary Sjö gren's syndrome. J Rheumatol 2005; 32(12): 2351-5.&lt;/p&gt;&lt;p&gt;Sirois A.D., Natelson B. Clinicopathological findings consistent with primary Sjö gren's syndrome in a subset of patients diagnosed with chronic fatigue syndrome: preliminary observations. J Rheumatol 2001; 28(1): 126-31.&lt;/p&gt;&lt;p&gt;Andersson S.I., Manthorpe R., Theander E. Situational patterns in coping with primary Sjö gren's syndrome. Psychol Health Med 2001; 6(1): 29-40.&lt;/p&gt;&lt;p&gt;Johnson E.O., Kostandi M., Moutsopoulos H.M. Hypothalamic-pituitary-adrenal axis function in Sjö gren's syndrome: mechanisms of neuroendocrine and immune system homeostasis. Ann NY Acad Sci 2006; 1088: 41-51.&lt;/p&gt;&lt;p&gt;Dohrenbusch R., Grü terich M., Genth E. Fibromyalgia and Sjö gren's syndrome-clinical and methodological aspects. J Rheumatol 1996; 55(1): 19-27.&lt;/p&gt;&lt;p&gt;Champey J., Corruble E., Gottenberg J.E. et al. Quality of life and psychological status in patients with primary Sjö gren's syndrome and sicca symptoms without autoimmune features. Arthr Rheum 2006; 55: 451-7.&lt;/p&gt;&lt;p&gt;Karaiskos D., Mavragani C.P., Sinno M.H. et al. Psychopathological and personality features in primary Sjö gren's syndrome - associations with autoantibodies to neuropeptides. Rheumatology (Oxford) 2010; 49(9): 1762-9.&lt;/p&gt;&lt;p&gt;Wang Y., Wang S.L., Zou Y.Z. Psychiatric and central nervous system involvement in Sjö gren's syndrome. Zhonghua Kou Qiang Yi Xue Za Zhi 2004; 39(2): 158—60.&lt;/p&gt;&lt;p&gt;Herbert J., Goodyer I.M, Grossman A.B. et al. Do corticosteroids damage the brain? J Neuroendocrinol 2006; 18(6): 393—411.&lt;/p&gt;&lt;p&gt;Lewis D.A., Smith R.E. Steroid-induced psychiatric syndromes. A report of 14 cases and a review of the literature. J Affect Disord 1983; 5(4): 319-32.&lt;/p&gt;&lt;/div&gt;&lt;br /&gt;</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
